ClinicalTrials.Veeva

Menu

Pharmacogenomics Blood Sampling Protocol For Irinotecan/Fluorouracil/Leucovorin(CPT-11/FU/LV).

Pfizer logo

Pfizer

Status and phase

Completed
Phase 4

Conditions

Colorectal Neoplasms

Treatments

Procedure: Blood draw

Study type

Interventional

Funder types

Industry

Identifiers

NCT00140036
A5961020
CPTAIV-0020-366

Details and patient eligibility

About

This protocol describes procedures for the collection of blood samples for the intent of determining genetic contribution to the safety and efficacy of CPT/FU/LV.

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Participation in studies employing treatment with irinotecan and a signed informed consent.

Exclusion criteria

  • None.

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

Trial contacts and locations

34

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems